Comparison of risk factors for candidemia versus bacteremia in hospitalized patients

Infection

Volumn 34, Issue 6, 2006, Pages 322-327

  Amrutkar, P P ^a   Rege, M D ^a   Chen, H ^a   LaRocco, M T ^b   Gentry, L O ^b   Garey, K W ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BLOOD CULTURE; BLOOD FLOW; BOOTSTRAPPING; CANDIDEMIA; CENTRAL VENOUS CATHETER; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; EMPIRICISM; FEMALE; GASTROINTESTINAL SURGERY; HEART DISEASE; HEMODIALYSIS; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEUTROPENIA; PATIENT IDENTIFICATION; RISK FACTOR; TOTAL PARENTERAL NUTRITION; VALIDITY;

ADULT; AGED; BACTEREMIA; CANDIDIASIS; CARDIOVASCULAR DISEASES; CROSS INFECTION; FEMALE; HOSPITALS, GENERAL; HUMANS; INTENSIVE CARE UNITS; LUNG DISEASES; MALE; MIDDLE AGED; ODDS RATIO; PARENTERAL NUTRITION, TOTAL; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; TEXAS;

EID: 33845711017     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-006-5677-4     Document Type: Article

References (30)

1. Bouza E, Sousa D, Munoz P, Rodriguez-Creixems M, Fron C, Lechuz JG: Bloodstream infections: a trial of the impact of different methods of reporting positive blood culture results. Clin Infect Dis 2004; 39: 1161-1169.
2. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP: National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. Diagn Microbiol Infect Dis 1998; 31: 327-332.
3. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB: Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-317.
4. Morrell M, Fraser VJ, Kollef MH: Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 2005; 49: 3640-3645.
5. Macphail GL, Taylor GD, Buchanan-Chell M, Ross C, Wilson S, Kureishi A: Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals. Mycoses 2002; 45: 141-145.
6. Rentz AM, Halpern MT, Bowden R:The impact of candidemia on length of hospital stay, outcome, and overall cost of illness. Clin Infect Dis 1998; 27: 781-788.
7. McKinnon PS, Coff DA, Kern JW, Devlin JW, Barletta JF, Sierawski SJ, Mosenthal AC, Gore P, Ambegaonkar AJ, Lubowski TJ: Temporal assessment of candida risk factors in the surgical intensive care unit. Arch Surg 2001; 136: 1401-1408; discussion 1409.
8. Puzniak L, Teutsch S, Powderly W, Polish L: Has the epidemiology of nosocomial candidemia changed? Infect Control Hosp Epidemiol 2004; 25: 628-633.
9. Blumberg HM, Jarvis WR, Soucie JM, Edwards JE, Patterson JE, Pfaller MA, Rangel-Frausto MS, Rinaldi MG, Saiman L, Wiblin RT, Wenzel RP: Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey. Chin Infect Dis 2001; 33: 177-186.
10. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP: Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1989; 149: 2349-2353.
11. Zaas AK, Song X, Tucker P, Perl TM: Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002; 35: 1139-1146.
12. von Baum H, Ober JF, Wendt C, Wenzel RP, Edmond MB: Antibiotic-resistant bloodstream infections in hospitalized patients: specific risk factors in a high-risk population? Infection 2005; 33: 320-326.
13. Rex JH, Bennett JE, Sugar AM, Pappas PC, van der Horst CM, Edwards JE, Washburn RG, Scheid WM, Karchmer AW, Dine AP, et al.: A randomized trial comparingfluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med 1994; 331: 1325-1330.
14. Steyerberg EW, Eijkemans MJ, Harrell FE, Jr., Habbema JD: Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets. Med Decis Making 2001; 21: 45-56.
15. Chen CH, George SL: The bootstrap and identification of prognostic factors via Cox's proportional hazards regression model. Stat Med 1985; 4: 39-46.
16. West DC, Marcin JP, Mawis R, He J, Nagle A, Dimand R: Children with cancer, fever, and treatment-induced neutropenia: risk factors associated with illness requiring the administration of critical care therapies. Pediatr Emerg Care 2004; 20: 79-84.
17. Ostrosky-Zeichner L: New approaches to the risk of Candida in the intensive care unit. Curr Opin Infect Dis 2003; 16: 533-537.
18. Morgan J: Global trends in candidemia: review of reports from 1995-2005. Curr Infect Dis Rep 2005; 7: 429-439.
19. Luzzati R, Amalfitano G, Lazzarini L, Soldani F, Bellino S, Solbiati M, Danzi MC, Vento S, Todeschini G, Vivenza C, Concia E: Nosocomial candidemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000; 19: 602-607.
20. Alonso-Valle H, Acha O, Garcia-Palomo JD, Farinas-Alvarez C, Fernandez-Mazarrasa C, Farinas MC: Candidemia in a tertiary care hospital: epidemiology and factors influencing mortality. Eur J Clin Microbiol Infect Dis 2003; 22: 254-257.
21. Peset V, Tallon P, Sola C, Sanchez E, Sarrion A, Perez-Belles C, Vindel A, Canton E, Gobernado M: Epidemiological, microbiological, clinical, and prognostic factors of bacteremia caused by high-level vancomycin-resistant Enterococcus species. Eur J Clin Microbiol Infect Dis 2000; 19: 742-749.
22. Chien LY, Macnab Y, Aziz K, Andrews W, McMillan DD, Lee SK: Variations in central venous catheter-related infection risks among Canadian neonatal intensive care units. Pediatr Infect Dis J 2002; 21: 505-511.
23. Jensen AG, Wachmann CH, Poulsen KB, Espersen F, Scheibel J, Skinhoj P, Frimodt-Moller N: Risk factors for hospital-acquired Staphylococcus aureus bacteremia. Arch Intern Med 1999; 159: 1437-1444.
24. Saubolle MA: Fungal pneumonias. Semin Respir Infect 2000; 15: 162-177.
25. Michalopoulos AS, Geroulanos S, Mentzelopoulos SD: Determinants of candidemia and candidemia-related death in cardiothoracic ICU patients. Chest 2003; 124: 2244-2255.
26. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R: Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg 1994; 220: 751-758.
27. Nucci M, Colombo AL: Risk factors for breakthrough candidemia. Eur J Clin Microbiol Infect Dis 2002; 21: 209-211.
28. Apostolopolou E, Katsaris G, Katostaras T: Risk factors for nosocomial bloodstream infections. Br J Nurs 2003; 12: 718, 720-726.
29. Danzig LE, Short LJ, Collins K, Mahoney M, Sepe S, Bland L, Jarvis WR: Bloodstream infections associated with a needleless intravenous infusion system in patients receiving home infusion therapy. Jama 1995; 273: 1862-1864.
30. Laupland KB, Zygun DA, Davies HD, Church DL, Louie TJ, Doig CJ: Population-based assessment of intensive care unit-acquired bloodstream infections in adults: incidence, risk factors, and associated mortality rate. Crit Care Med 2002; 30: 2462-2467.